These NDCs maintain chemosensitivity as parental cancer cells and gain malignant properties; in particular, these NDCs demonstrate enhanced metastatic capacities through ATF4‐dependent nonclassical NF‐κB signaling activation. The gene discussed is NFKB1; the disease is cancer.